| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1200030 | 注射用重组人源化抗肿瘤坏死因子α单克隆抗体 | adalimumab | Injection | Biological Products(1) | New Drug Application | 2012-06-19 | 珠海市丽珠单抗生物技术有限公司 | Livzon Mabpharm INC | Certificate Issued | 2014-03-04 | view |